Celebrities, Civil Rights Leaders Rally To Stop 86-Year-Old Black Farmer From Losing 500 Acre Family Farm

Health insurance giant UnitedHealthcare® set to auction off the Black-owned farm

This ordeal is killing me, at 86-years-old I never imagine losing the one thing my family worked so hard for and is a part of our family legacy.”

— Lee Holley, Farm Owner

DALLAS, TX, USA, February 28, 2021 /EINPresswire.com/ — An African American farmer and his brothers from Omaha, Texas, are pleading for the public’s help to stop the farm they pooled their money together to purchase in 1968 from being auctioned off after a dispute with UnitedHealthcare® that has nothing to do with the farmers or their farm. The attempt to seize the farm amidst a President approved statewide winter emergency and the global pandemic has gotten the attention of celebrities and civil rights leaders who are lending their voice and social media platforms to bring attention to the issue.

86-year-old cattle farmer Lee Holley and his two brothers, Willie and Rudolph, say they have fought off racism and death threats over the years from people who have not supported seeing the 500-acre property in the hands of an African-American family. But they can’t fight off a lawsuit by the healthcare giant threatening to destroy the family’s legacy and everything they have lived and worked for over the years.

“Our family is heartbroken over this,” said Holley. “This farm is everything we have and the only life my brothers and I have known. We have raised our children and grandchildren here, and we would do anything to save it.”

The lawsuit with United healthcare is over medical claims involving Lee’s 60-year-old daughter, Dr. Lisa Holley, an anesthesiologist from Dallas. UnitedHealthcare® alleges that they overpaid for surgeries she billed through her medical practice, LH Medical, which Dr. Holley disputes. A two-million-dollar default judgment by the court opened up an opportunity for UnitedHealthcare® to come after everything, including the family farm. Dr. Holley says it is held in a family trust and should not be a part of this settlement.

“This feels like a modern-day lynching,” said Dr. Holley. “African American’s never got their 40-acres and a mule, and here you have a family who had to fight all kinds of racism to buy this farmland in the middle of the civil rights movement in the 1960s. It is even harder to keep it, only now to watch it stolen over a financial matter having nothing to do with the farm.

Lee Holley believes this is part of a larger conspiracy to rob Black Farmers of their land. This month, the Senate announced The Justice for Black Farmers Act to protect remaining Black farmers from losing their land. The act will provide land grants to create a new generation of Black farmers, restore the land base lost, and implement systemic reforms to help family farmers across the United States. According to US Senator Cory Booker, there were nearly one million Black farmers in the United States in 1920. Unfortunately, due to the history of discrimination, it is estimated that there are less than 50,000 remaining Black farmers.

“This should be criminal,” said Holley. “This ordeal is killing me; at 86-years-old I never imagine losing the one thing my family worked so hard for and is a part of our family legacy. If I had the money to pay United Healthcare myself, I would, but I am an elderly farmer trying to fight a healthcare giant.” My family and I are not asking for a handout; we are merely praying for a miracle,”

A crowdfund has been established by a notable, award-winning journalist and founder of iWomanTV, Cathleen Trigg-Jones, to shine a national spotlight on the issue and help the family raise money to save the farm.

A sheriff’s auction for the farm is scheduled for March 2, 2021, at 10 AM on the Morris County Courthouse’s steps in Omaha, Texas.

Nikkia T MCCLAIN
Tene Nicole, Marketing and Public Relations
+1 646-244-2140
email us here

Help Save Black Owned Farm From Auction!


Source: EIN Presswire

Oral and Maxillofacial Surgery San Francisco Announces New Posts on Maxillofacial Surgery in the Bay Area

Maxillofacial Surgery in the San Francisco Bay Area

Oral and Maxillofacial Surgery San Francisco is proud to announce a new milestone for its blog page.

I'm proud to say my experience in maxillofacial surgery is one of the reasons people come to see me, but it's not the only reason.”

— Dr. Alex Rabinovich

SAN FRANCISCO, CALIFORNIA, UNITED STATES, February 28, 2021 /EINPresswire.com/ — Oral and Maxillofacial Surgery San Francisco (https://www.oralsurgery-sf.com/), a team of hard-working oral surgeons in San Francisco, is proud to announce a new milestone on the clinic blog page. Several blog posts reflect on various reasons for visiting a maxillofacial surgeon in the Bay Area. Dr. Alex Rabinovich evaluates both the structural issues and personal stories of patients before surgery. Acknowledging emotional trauma and supportive post-op visits could help ensure a successful outcome.

"I'm proud to say my experience in maxillofacial surgery is one of the reasons people come to see me, but it's not the only reason," explained Dr. Alex Rabinovich, head of Oral and Maxillofacial Surgery San Francisco. "The personal toll a traumatic jaw problem takes needs to be factored in too. There is emotional as well as physical healing to plan during post-op."

Interested readers can learn more at the following URL: https://www.oralsurgery-sf.com/blog/. A broken or misaligned jaw can be a traumatic experience. Each personal story could carry details about emotional anguish. A professional maxillofacial surgeon in the Bay Area combines expertise and listening skills to help patients achieve better surgical outcomes. Patients throughout the Bay Area from San Jose to Pleasanton to Oakland can review the page for Dr. Rabinovich https://www.oralsurgery-sf.com/meet-dr-rabinovich/. Interested persons can learn more about Dr. Noah Sandler at https://www.oralsurgery-sf.com/sandler/. Those with dental implant problems can also visit https://www.sfdentalimplants.com/ as well as the Visage website at https://visage-sf.com/.

MAXILLOFACIAL SURGEON IN BAY AREA KNOWS EVERY PATIENT 'HAS A STORY'

Here is the background on this release. Traumatic stories may seem commonplace in the news, but if an individual experiences a personal ordeal, it can destroy their quality of life. A car crash resulting in a broken jaw or face can cause daily anguish for the victim. Missing teeth and diseased jawbones might be an embarrassment and destroy a persons' self-esteem. Before scheduling surgery, a maxillofacial surgeon may need to listen to a Bay Area residents’ story. An oral surgeon considers personal stories a central component to achieving successful jaw surgery. The type of physical and emotional discomfort can help secure a successful surgery plan. Discussions can include various types of maxillofacial surgery, including the following: orthognathic surgery, facial reconstruction, wisdom teeth removal, and dental implants. For these reasons, Oral and Maxillofacial Surgery San Francisco announce a new milestone for the clinic blog page.

ABOUT ORAL AND MAXILLOFACIAL SURGERY SAN FRANCISCO

Oral and Maxillofacial Surgery San Francisco (http://www.oralsurgery-sf.com/) is located in the Financial District of the City. Under the direction of Dr. Alex Rabinovich, a Board Certified Oral and Maxillofacial Surgeon. Extensive training and years of focused oral surgery experience sets Alex Rabinovich MD DDS apart from the growing number of general dentists offering oral surgery and other dental procedures. Procedures include wisdom teeth extraction, Orthognathic or jaw surgery, sleep apnea mouth appliances, and dental implants. Dr. Rabinovich is also available for emergency oral surgery in the San Francisco environs. Oral Surgery San Francisco serves all neighborhoods in the city of San Francisco, including Pacific Heights, Russian Hill, and Noe Valley.

Lee McDonald
JM Internet Group
+1 415-655-1071
email us here


Source: EIN Presswire

Kimtron Hi-Rad x-ray systems with patented Photon Purification™ Technology to be used in Cannabis Decontamination

OXFORD, CT, UNITED STATES, February 28, 2021 /EINPresswire.com/ — The Situation
Whether grown in indoor or outdoor environments, the cannabis plants’ physical characteristics leave it susceptible to a host of microbial pathogens. These pathogens, including molds, fungi, and yeasts, are generally harmless but can present a health threat to immunosuppressed individuals. Coliforms, such as E. coli and salmonella, which can also be present under certain circumstances, can be harmful to anyone.

Microbiologists use the term “colony-forming units” (CFU’s) to describe the number of pathogen cells present in a sample. Harvested cannabis having a high CFU count is a primary reason why cannabis growers fail their respective state’s regulatory compliance testing (cannabis remains illegal at the Federal level, therefore, National guidelines governing product purity do not yet exist). Product that cannot be remediated (purified) is typically destroyed or cooked-down into lower margin oils and edibles.

Currently, there are several methods of cannabis microbial remediation including chemical washing, cold plasma exposure, RF bombardment, and ozone saturation. None have proven as effective as ionizing radiation (X-ray and Gamma) which is the preferred method of remediation in Canada and several “more cannabis-developed” countries.

Kimtron’s Role
Early in 2014, Kimtron was approached by a group of individuals who, anticipating the inevitability of a legal US cannabis market, were intent on selecting the products, supplies, and quality control measures necessary to grow and distribute cannabis. The group identified Kimtron as a unique, vertically integrated x-ray system manufacturer capable of designing and producing a cannabis purification system. Their goal was to target emerging cannabis growers and bundle irradiators along with other grow-related products and services.

Kimtron engineered a cannabis irradiator system for the group in 2014 but they were financially unable to commission Kimtron to produce such a system. The group eventually disbanded and Kimtron refocused efforts on its core products for the Non-Destructive Testing (NDT) industry which was experiencing unprecedented growth at the time. Kimtron management dismissed the cannabis event seeing it as an interesting but not yet viable market.

Recent events indicate the group from 2014 was right on target albeit five to six years ahead of their market. Responding to requests from major growers, in late Q-4 2020, Kimtron developed a prototype system and employed two major Universities and a well-known private laboratory to oversee test criteria and results. Kimtron is encouraged by the system’s better-than-expected performance and is positioned to bring systems to market in Q-2 2021.

Peter Cawley, Kimtron CEO states; “Electrically initiated radiation has already been proven a safe and e¬ffective means of eliminating pathogens in consumables, that wasn’t our charge. The most important factor in the design criteria of our Hi-Rad family of products was the need to deliver a high dose of energy with unrivaled precision, accuracy, and reliability. This is primarily a function of the high voltage power supply (HVPS), the heart of any x-ray system, and our patented HVPSs built in our US-based facility ensures repeatable results and increased throughput, which is a key concern for the larger growers”.

Cawley further states; “We find ourselves in an opportune position given the technical capability of our company and our ability to produce industry-leading high-power x-ray components. Originally developed for harsh industrial use, our products have proven uniquely suited for this application. We anticipate rapid growth.”

David Somoroff, Kimtron VP of Marketing states; “I’ve been an individual investor in the cannabis industry for some time and have observed many growers struggle with compliance issues. At a price point of several hundred to several thousand dollars per pound retail, no cannabis grower is happy about having to destroy product due to high CFU counts. We believe we have a superior product that will assist our customers in delivering a safe and pure product to the consumer.”

About the Company
Kimtron Inc. was formed in 1991 as an Industrial x-ray sales and service organization that has since developed into an ISO-9001 certified design and manufacturing firm of patented, proprietary X-ray systems and components. The company serves hundreds of customers in a variety of industries including Medical Research, Aerospace, Metal Casting, Defense, and Homeland Security. Kimtron enjoys a reputation for producing world-class products and delivering unrivaled after-sale service. Kimtron is 100% American-owned and produces all systems and components in the USA.

Peter Cawley
Kimtron Inc
+1 203-262-3361
email us here


Source: EIN Presswire

Development of microRNA-based TREATMENTS for MYOTONIC DYSTROPHY Type 1 by Translational Genomics Group

Dr. Artero working on rare diseases

Logo for TATAMI project aiming therapies against myotonic dystrophy

Dr. Artero’s Lab, based in Spain (University of Valencia), is a pioneer in discovering therapeutic targets and innovative drug candidates for rare diseases

VALENCIA, VALENCIA, SPAIN, February 28, 2021 /EINPresswire.com/ — Translational Genomics Group (Dr. Artero’s Lab), a Spanish research laboratory affiliated to the University of Valencia (UVEG) and INCLIVA Biomedical Research Institute, is a pioneer in discovering therapeutic targets and innovative drug candidates for rare diseases, has announced the development of novel DM1 (Myotonic Dystrophy Type 1) therapies based on recent new knowledge on microRNA class molecules. Being the most common muscular dystrophy in adults, affecting around 90,000 people in Europe and 75,000 in the US, the researchers from the Translational Genomics Group announced that their DM therapy could help these people and improve their quality of life.

About Myotonic Dystrophy Type 1

Myotonic dystrophy type 1 (DM1) is a life-threatening and chronically debilitating disease. The estimated incidence of the disorder worldwide is approximately one in 3,000-8,000 people, making it the most frequent adult muscular dystrophy. The disorder is inherited as an autosomal dominant trait, meaning that a child must inherit only one copy of the defective gene from one parent to develop the disease. Individuals born from individuals who are carriers of the mutated gene usually display age anticipation and higher severity for the clinical disease progression. Currently, there is no cure available to arrest or retard disease progression. Therefore, possible treatments are urgently needed since clinical management is limited to symptomatic care.

DM1 displays a wide range for onset of the clinical signs, including neonatal and infantile, to later adult forms being diagnosed. In a common clinical path, DM1 patients always manifest an important degree of progressive locomotor muscle weakness, atrophy, and myotonia, with the addition of less known, but also frequent, respiratory and cardiac impairments connected to other muscles degeneration, eventually leading to premature death, neurological issues causing social disabilities, and features outside the neuromuscular spectrum, including diabetes, cataracts, and higher cancer incidence.

Caused by an expansion of CTG repeats in a non-coding region of the DMPK gene, DM1 was the first disease ever described for which the underlying cause of the pathology involves an RNA-gain-of-function (RNA toxicity) mechanism. Upon transcription, expanded CUG in DMPK mRNAs form stable hairpin structures retained in the cell nucleus where they contribute to the abnormal binding and functional depletion of important factors strongly involved in RNA metabolism. Specifically, the limited availability of Muscleblind-like family factors (MBNLs) is the most significant contribution to DM1 phenotypes, like cardiac conduction problems, myotonia, and insulin resistance. However, the causes of other former critical clinical features in DM1 patients, like the significant muscular atrophy, are still not understood.

About Translational Genomics Group (Dr. Artero’s Lab):

Translational Genomics Group currently aims to identify therapeutic targets and develop innovative treatments for rare neuromuscular diseases (www.uv.es/gt). Very focused on DM1 from the very beginning, Dr. Artero and his team have provided the community with significant scientific advances that are now practical tools to push forward the development of novel drugs against DM1. Thus, their practical and rapid drug screening approaches have helped to identify and validate several chemical compounds, some licensed to the industry, for their further development in DM1. Dr. Artero´s long-term vision is highly relevant and transformative in filling in the gap between drug discovery and development in DM1 by leading the engagement of a multidisciplinary-driven effort to translate the results into actual treatments.

During the last years, Dr. Artero´s research has tracked to the DM1 field new actors to act together in a coordinated manner, intending to move novel candidate drugs to their next step. Research groups from top-notch European institutions such as Oxford University (UK) and CSIC (Spain), involved in medicinal chemistry of therapeutic oligonucleotides; Institute of Myology (France), developing novel animal model experimentation; IBEC (Spain), developing 3D tissue bioengineering; IIS Biodonostia (Spain), studying clinical evolution of the disease, are now directly involved in DM1 research through ongoing multidisciplinary projects like TATAMI (being funded by “la Caixa” Banking Foundation under the project code HR17-00268) or PROMETEO (being funded by regional Valencian Government) both coordinated by Dr. Artero. Significantly, non-scientific stakeholders are also involved in these projects to increase the chances of subsequent efforts, including national (ASEM Federation) and international (Myotonic Dystrophy Foundation) patient associations, research transfer offices, and regulatory CROs. At this moment, Dr. Artero is pursuing the construction of an European network for DM1 translational research with the incorporation of additional partners at scientific and non-scientific levels.

About microRNAs and DM1

In the last years, Dr. Artero’s group has pioneered the deciphering of small RNA regulatory molecules, called microRNAs (miRNAs), on distinct DM1 disease features.

By characterizing the miRNA-linked repression of the endogenous MBNL genes as an overlaid layer of regulation to the MBNL depletion pathway, they found two specific miRNAs (miR-23b and miR-218) that repress the expression of MBNL1 and MBNL2. Thus, the group has designed antisense oligonucleotides (AONs) that block the repressive miRNAs (antagomiRs), which have provided proof-of-concept to improve DM1-like alterations in a mouse model of the disease. Importantly, these results, under patent protection and recently published in the journal Nature Communications, led the creation, at the end of 2019, of a spin-off company of the University of Valencia, ARTHEx Biotech (www.arthexbiotech.com), that rapidly grown the interest of private investors at the bio & health field, completing an initial seed-round of 8M $ for the optimization of the drug candidate, subsequent preclinical regulatory studies, and design of the first clinical trial.

In a parallel research line, Dr. Artero´s group has recently published in Molecular Therapy Nucleic Acids how miR-7 contributes to the muscle atrophy phenotype in DM1 by studying its consequences replenishing or blocking miR-7 by using specific agomiR and antagomiR oligonucleotide molecules, respectively. Importantly, they highlighted that miR-7 dysfunction was linked to the alteration of catabolic muscle processes through autophagy- and atrophy-related pathways and support that restoration of miR-7 levels is a candidate therapeutic target counteracting muscle atrophy in DM1. A broader characterization of the molecular pathway for DM1 muscle atrophy is currently ongoing.

Want to crowdfund us? Contact at mecenzago@incliva.es
Want to collaborate with us? Contact at ruben.artero@uv.es

Rubén Artero Allepuz
Universidad de Valencia (SPAIN)
email us here

TATAMI research project: Trying to win the fight against Myotonic Dystrophy Type 1


Source: EIN Presswire

Best hairspray for men by Da'Dude Surpasses 550 Reviews on Amazon.co.uk

best hairspray for men

Da’Hair Spray

Best mens hairspray

best mens hairspray

Best hairspray for men Amazon

Amazon UK reviews

Best hairspray for men Da’Hair Spray from Da’Dude has gained an average 4.4 rating on Amazon UK after 550 reviews.

I'm writing this review as after years of monkeying around with different hair products, I think I have found the right one for me”

— Amazon customer Gee S

LONDON, GREATER LONDON, UK, February 28, 2021 /EINPresswire.com/ — Da’Hair Spray has reached a significant milestone with over 550 customer reviews on Amazon UK. The Da’Dude product has garnered a significant rating of 4.4 out of 5 stars. Most customers are delighted with the hair spray and continue to make Da'Dude a popular brand for men.

Da’Hair Spray keeps men’s hair in place all day due to its firm hold. Hairstyles can stand up to wind and even rain. Yet the spray doesn’t give a stiff or unnatural look. The hair isn’t limp either. It’s just perfectly styled all day. Da’Hair Spray provides a matte finish and leaves no residues on the hair.

This hair spray for men has a mild, zesty smell. It’s easy to remove at the end of the day with a brush or a wash. It offers great value for money. A few short sprays provide long-lasting results. The spray comes in a large 400ML bottle, this large size, gives more value to customers by lasting longer than cheaper brands.

Da’Hair Spray in the UK can be purchased on this link https://www.amazon.co.uk/DaDude-Hair-Spray-Men-Hairspray/dp/B00U6MROMO

Da’Dude who manufactures this hairspray is a family-owned manufacturer of men’s hair care products. They pride themselves on high-quality products and exceptional customer service. Visit their shop or learn more by clicking on https://www.dailymoss.com/how-to-use-hairspray-a-guide-for-men-by-dadude/

Gary Young
YoungHair AB ltd
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Best hairspray for men – how to use it.


Source: EIN Presswire

USA Merchants Targeting YoReSpot

YoReSpot

YoReSpot

Brandon Irlbeck (CEO YoReSpot)

Brandon Irlbeck (CEO YoReSpot)

BAYARD, IOWA, UNITED STATES, February 27, 2021 /EINPresswire.com/ —
There’s a new social media that is making waves with people from all over and with all backgrounds. The site is called YoReSpot. Created and funded by Brandon Irlbeck of Bayard, Iowa, this site was started with the belief that all people can come together without anyone experiencing the widespread censorship that other sites enforce. Whether it’s for a meme that you post, a comment made to someone, or even for liking things too much, too fast; this censorship has gotten out of hand, and it is only furthering the divide between people. YoReSpot has many features for it’s users to enjoy, including going live, calling in messenger, games, blog section and so much more. Not only does it have a familiar feel, but it runs smooth and the peaceful community like feel is astounding. A site for unity, for peaceful interactions, no matter what your spiritual beliefs, political or personal views are.

Despite standing up for unity, this site has not been met by everyone with open arms, including some other companies. In November of 2020, YoReSpot decided to use PayPal, Inc. for a one time payment of $9.99 for an ad-free version of the social networking site. This option removes ads, and also helps support the independently owned company. After just one week of use, PayPal emailed Irlbeck, CEO of YoReSpot, to inform him they were permanently suspending his business account. PayPal emails stated they did not have to explain why or how they came to this decision of action. Naturally, wanting to know why, a phone call took place between Irlbeck and PayPal in December of 2020. The PayPal representative stated that the company didn’t want anything to do with a site promoting Save the Children and Fund Homeless Vets movements, then proceeded to hang up on Irlbeck. They have since refused to engage in further contact with Irlbeck or his team and are still holding the money. “PayPal put a hold on a pretty decent chunk of change and said they would not release it for 180 days,” Irlbeck states, “none of this makes any sense to me. We haven’t done anything against their Terms of Service.”

Following the PayPal incident, Irlbeck decided to switch to Stripe for monetizing. Stripe was founded by John and Patrick Collison, with Patrick as the CEO. Things went very smooth with Stripe for a couple months, and Irlbeck thought that those issues were all in the past. Then on 2/26/2021, Stripe emailed Irlbeck saying they have permanently canceled the account and are holding the funds for 120 days. When Irlbeck tried to get an explanation, he got the familiar response that Stripe has the right to refuse to explain why his account was suspended permanently. “Here’s the kicker though,” Irlbeck says, “Stripe will not even allow me to refund users, they have locked my account completely.” So, Stripe is not just holding the money, but refusing to allow refunds as well; they’re effectively taking control of money that isn’t legally theirs, without a word of why or any communication thereafter.

Irlbeck has emailed his team of lawyers and is waiting back to find out if YoReSpot can take any legal action. “They have already gone through every transaction,” Irlbeck states, “and have concluded that neither PayPal or Stripe’s Terms of Service were not violated, in any way.” Some of his users have asked if there is anything they can do, while others are even calling for a boycott of Stripe and PayPal, Inc. for this ludicrous action made against such a respected and hardworking businessman. Irlbeck has vowed to do his best to find a payment company that does not have these policies and won’t shut accounts down without just cause.

Brandon L Irlbeck
YoReSpot
+ 16417450003
email us here


Source: EIN Presswire

STEMPilot Launches STEMPilot@Home Remote / Distance STEM Learning

STEMPilot@Home is our remote / distance learning program where students learn the theory of flight while learning to fly a flight simulator on smartphones

WATERBURY, CT, USA, February 27, 2021 /EINPresswire.com/ — STEMPilot @Home™ – Product Launch

STEMPilot @Home™, a self-directed virtual learning program using NGSS-aligned lesson plans and curriculum. The program uses flight simulation as a visual learning tool to apply K-12 S.T.E.M. engineering, science, and math while learning from home, computer lab, or as an after-school activity. Students learn the theory of flight while training on an online flight simulator smartphones, tablets or Chromebooks (with controller).
The program is easily installed into Google Classroom or Canvas.

"Engaging Students in STEM with Flight Simulation " We demonstrate to kids future careers in engineering, aviation, air traffic control, coding, airframe and powerplant and science. We can help you accomplish this in your school,” says founder, Jay LeBoff.

❖ Pioneered with visual learning at the forefront, students are challenged to watch videos on the subject, read the lesson, fly the simulator, and pass the quiz to move onto the next lesson.
❖ Meaningful “Project-Based Learning”.
❖ Demonstrates real-world usefulness of STEM with applications in aviation and engineering.
❖ Easy to follow multimedia-supported lesson plans.
❖ Designed to fit all learning environments, whether it is in the class or at home.
❖ Available online: www.stempliot.com

Flying Students into Great Careers™

Company Information: STEMPilot Inc’s manufacturers STEMPilot Flight Simulators, STEMPilot@Home and SAFEDrone, all classroom curriculums.

For more information on our latest product, interviews, or photo opportunities, contact jay@stempilot.com or call 914-262-1366 for press inquiries or interviews.

jay LeBoff
STEMPilot Inc.
+1 914-232-1366
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Alexander James Rodriguez Drops ‘Doesn’t Matter To Me’

Doesn't Matter To Me Cover Art

‘Doesn’t Matter To Me’ Cover Art

Teen sensation Alexander James Rodriguez releases his debut ballad, 'Doesn't Matter To Me' with beautiful lyrics

LOS ANGELES, CALIFORNIA, USA, February 27, 2021 /EINPresswire.com/ — Alexander James Rodriguez, who began his music career at age 12 during the height of last year's pandemic, has released his first record of 2021, ‘Doesn’t Matter To Me’ on all platforms. This is the first single he actively wrote on, and what makes this ballad stand out, are the lyrics we can all relate to right now.

‘Doesn’t Matter To Me’ is a touching coming-of-age song that the singer-songwriter co-wrote with Alex Jacke and Liz Rodriguez. The record, which was recorded in North Hollywood, has a very impactful message for fans and new listeners.

"When we first heard the beat, it was apparent the message was about love or relationships, but I didn’t want to just write another love song, I really wanted something fitting for the times we currently live in – things that affect our daily lives now. So, the song became about forbidden love whether that be a forbidden friendship or love interest from family, friends, or peers. And ultimately their approval doesn’t matter because love, however it comes, always finds a way.” said Rodriguez.

Although new to the music industry, the 13-year-old actor and singer-songwriter has formally cemented his career in music by winning the 2021 ‘Rising Star Award’ at the Hollywood Music in Media Award, alongside music giants John Legend, Justin Timberlake, and Kenny Loggins.

Fans of Alexander James Rodriguez only have a short time to wait for the song's music video. The official 'Doesn’t Matter To Me' music video, which was filmed in Los Angeles on February 21, is releasing on Friday, March 5.

‘Doesn’t Matter To Me’ from Alexander James Rodriguez is currently out and available for download on iTunes and all digital streaming platforms including Apple Music, Spotify, Amazon Music, YouTube Music, TikTok, Pandora, DEEZER, and more!

Liz Rodriguez
EMR Media
+1 310-435-3634
email us here

Doesn’t Matter To Me


Source: EIN Presswire

MillionaireMatch Don’t Allow Users To Post “Bikini Photos” Via Public Albums

LOS ANGLES, CALIFORNIA, US, February 27, 2021 /EINPresswire.com/ — MillionaireMatch, an established, high-quality dating site for affluent singles, has announced a new online policy for user photos shared on its platform. An online network where top-tier professionals can meet, connect, and develop serious, long-term relationships, MillionaireMatch is moving past the looks by prohibiting semi-nude or oversexualized content, including bikini photos in public albums. Starting today, user-uploaded public photos must include a clear view of face, with no bikinis, bralettes, or underwear showing, whether indoors or outdoors.

According to MillionaireMatch, most users will swipe left the shirtless bathroom selfies. MillionaireMatch enacted the policy on bathing suit content, as well as shirtless bathroom selfies that follows the purpose of “Serious Millionaire Dating Site”. It announced that the policy was put into effect following complaints and research on the issue.

“This new policy will take steps to improve the community environment,” remarked Johnny Du, the Chief Operating Officer of MillionaireMatch. “MillionaireMatch will continue to hear its users today and beyond.”

To learn more, please visit MillionaireMatch.com. Millionaire Match is also available in the iOS App Store and Google Play Store.

About MillionaireMatch

MillionaireMatch has supported over 4.4 million successful and affluent users on its dating platform since 2001. MillionaireMatch has helped users connect with rich and high-quality singles, including top-tier professionals such as doctors, lawyers, celebrities, CEOs, and entrepreneurs, seeking an array of compatible qualities in a match.

Fiona Liu
MillionaireMatch
Press@MillionaireMatch.com


Source: EIN Presswire

Silicon Valley Institute Announces New Post for Robotic Hair Loss Surgery in San Francisco

Silicon Valley Hair Institute is proud to announce a new post for robotic hair loss surgery.

The ARTAS surgical system is a dream to work with. Even though I helped develop the robot, it continues to surprise me.”

— Miguel Canales, MD

SAN FRANCISCO, CALIFORNIA, UNITED STATES, February 27, 2021 /EINPresswire.com/ — Silicon Valley Hair Institute, a best-in-class clinic for hair loss mitigation in the San Francisco area at https://siliconvalleyhairinstitute.com/, is proud to announce a new post. New technology in the hair transplant arena can combine human knowledge and mechanical precision. The relationship may result in a thicker head of hair and a more youthful appearance.

"The ARTAS surgical system is a dream to work with. Even though I helped develop the robot, it continues to surprise me," explained Miguel Canales, MD. "Each hair transplant surgery is planned to help individual hair loss issues. Patients generally love the results and many have told me the post-op recovery is easier than they expected."

Men and women living in the Bay Area can review the post about robotic hair loss surgery from Silicon Valley Hair Institute https://siliconvalleyhairinstitute.com/if-you-want-a-robotic-hair-transplant-it-still-requires-a-surgeon-to-operate-it/. SVHI is one of the few clinics in the area to use the ARTAS hair transplant system. The hair transplant system can manage exceptional movements resulting in less scarring and a more natural appearance. Dr. Canales, a highly-skilled hair transplant surgeon, helped design and launch the ARTAS robot. Men and women ready to find hair loss solutions can contact Dr. Miguel Canales for a no-obligation consultation. SVHI is a 'full service' clinic supporting Bay Area residents with hair and skin rejuvenation. Interested persons can also visit the parallel cosmetic dermatology website at https://svaestheticderm.com/.

SURGEON-DRIVEN ROBOT 'RAISES THE BAR' FOR INNOVATIVE HAIR LOSS SURGERY IN SAN FRANCISCO AREA

Here is the background on this release. Silicon Valley technology continues to achieve medical breakthroughs in various surgical fields. Computerized devices have turned complicated surgeries into shorter, easier-to-manage procedures. Specifically, FUE/FUT hair transplant procedures can benefit from robotic hair loss surgery in San Francisco. A top hair transplant surgeon combined with a surgical robot can 'raise the bar' on patient results. Precise follicular hair extractions and transplantation can help diminish signs of scarring. A carefully planned surgery may result in a more natural appearance to the hairline. Post-op benefits for robotic hair loss surgery can include a comfortable and shorter recovery time. San Francisco residents ready to tackle hair loss can find a top surgeon and ARTAS robot nearby to help.

ABOUT THE SILICON VALLEY HAIR INSTITUTE

Silicon Valley Hair Institute (http://siliconvalleyhairinstitute.com/), under the leadership of top-rated California hair transplant surgeon Dr. Miguel Canales – is one of the best robotic hair transplant clinics in the San Francisco Bay Area. Dr. Canales provides both the FUT (FUT (Follicular Unit Transplant at http://siliconvalleyhairinstitute.com/fut-surgery/) and FUE hair transplant (Follicular Unit Extraction at http://siliconvalleyhairinstitute.com/fue-hair-transplant/) procedures. Dr. Canales is a top-rated hair transplant specialist for Bay Area residents. The Silicon Valley Hair Institute is a specialized hair clinic serving hair loss and hair restoration needs in San Francisco, San Jose, and the Silicon Valley Peninsula (Sunnyvale, Mountain View, Palo Alto, Los Altos, Menlo-Atherton, Redwood City, and beyond.). Dr. Canales also specializes in aesthetic hair restoration for females seeking eyebrow transplantation or hairline advancements.

Lee McDonald
JM Internet Group
+1 415-655-1071
email us here


Source: EIN Presswire